CRED NPM

05/11/2024

Internal

Allegra Case Study

Fexofenadine 120 mg tablets switch

Serenella Cascio

Orlane Jauvain

The Organisation for Professionals in Regulatory Affairs

The Organisation for Professionals i Regulatory Affairs

1

Internal

1. WHY? The importance of SAR treatment

2. Rationale for the Switch

3. Benefits of Reclassification

Agenda

4. Regulatory Background

5. Evidence Supporting the Switch

6. Considerations on application, claims and brand name

7. Success in Promoting Self-Care

The Organisation for Professionals in Regulatory Affairs

2

1